OBIO (STOCKS)
Orchestra BioMed Holdings, Inc. Ordinary Shares
$4.510000
+0.210000 (+4.88%)
Prev close: $4.300000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Medical Specialties
- CEO
- David P. Hochman
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $263.34M
- Employees
- 70
- P/E (TTM)
- -3.34
- P/B (TTM)
- 4.58
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
3
Strong Buy
9
Buy
2
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Dec 2025 (Q4)
|
$-0.13 | $-0.39 | +0.2561 | +66.33% |
|
Sep 2025 (Q3)
|
$-0.40 | $-0.44 | +0.0436 | +9.83% |
|
Jun 2025 (Q2)
|
$-0.50 | $-0.51 | +0.0138 | +2.69% |
|
Mar 2025 (Q1)
|
$-0.49 | $-0.49 | +0.0006 | +0.12% |
Financial Statements
| Revenues | $33.48M |
| Benefits Costs and Expenses | $86.18M |
| Cost Of Revenue | $190.00K |
| Costs And Expenses | $85.29M |
| Gross Profit | $33.29M |
| Operating Expenses | $85.10M |
| Selling, General, and Administrative Expenses | $26.91M |
| Research and Development | $58.19M |
| Operating Income/Loss | -$51.81M |
| Income/Loss From Continuing Operations After Tax | -$52.70M |
| Income/Loss From Continuing Operations Before Tax | -$52.70M |
| Income Tax Expense/Benefit | $0.00 |
| Net Income/Loss | -$52.70M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$52.70M |
| Net Income/Loss Available To Common Stockholders, Basic | -$52.96M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $254.00K |
| Preferred Stock Dividends And Other Adjustments | $254.00K |
| Basic Earnings Per Share | -$1.11 |
| Diluted Earnings Per Share | -$1.11 |
| Basic Average Shares | 47,747,078 |
| Diluted Average Shares | 47,747,078 |
| Assets | $114.86M |
| Current Assets | $107.91M |
| Inventory | $310.00K |
| Other Current Assets | $107.60M |
| Noncurrent Assets | $6.95M |
| Fixed Assets | $1.72M |
| Other Non-current Assets | $5.23M |
| Liabilities | $51.48M |
| Current Liabilities | $16.74M |
| Accounts Payable | $6.10M |
| Wages | $4.16M |
| Other Current Liabilities | $6.48M |
| Noncurrent Liabilities | $34.74M |
| Long-term Debt | $15.00M |
| Other Non-current Liabilities | $19.74M |
| Equity | $53.57M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $53.57M |
| Temporary Equity | $9.81M |
| Liabilities And Equity | $114.86M |
| Net Cash Flow From Operating Activities | -$48.96M |
| Net Cash Flow From Operating Activities, Continuing | -$48.96M |
| Net Cash Flow From Investing Activities | -$26.94M |
| Net Cash Flow From Investing Activities, Continuing | -$26.94M |
| Net Cash Flow From Financing Activities | $88.33M |
| Net Cash Flow From Financing Activities, Continuing | $88.33M |
| Net Cash Flow | $12.43M |
| Net Cash Flow, Continuing | $12.43M |
| Comprehensive Income/Loss | -$52.69M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$52.69M |
| Other Comprehensive Income/Loss | $8.00K |